Prisum Healthcare continues its geographic expansion through the strategic acquisition of Vitabiotics Turkey January 2026

Prisum Healthcare announces the successful completion of the acquisition of Vitabiotics Turkey. This transaction represents a significant milestone in the company’s geographic expansion strategy.

Prisum Healthcare, a leading healthcare company focused on improving quality of life through high-quality medical and nutritional solutions, announces the successful completion of the acquisition of Vitabiotics Turkey. This acquisition represents a significant milestone in the company’s geographic expansion strategy.

Through this transaction, Prisum Healthcare strengthens its position in the healthcare sector, building on its existing footprint in Europe, including Romania, Greece, and Bulgaria. Vitabiotics’ business in Turkey benefits from strong brand recognition and a proven growth trajectory, complementing Prisum Healthcare’s existing portfolio of globally respected brands.

Healthy Growth in a Key Market

Vitabiotics is one of the United Kingdom’s leading companies specializing in dietary supplements, including vitamins and minerals designed for all stages of life.

For nearly a decade, Vitabiotics Turkey has consolidated its presence in Turkey’s dynamic healthcare sector, a market that has experienced significant growth in dietary supplements. This acquisition enables Prisum Healthcare to leverage the success achieved in other markets where the company has operated for more than thirty years.

Vitabiotics products in Turkey will become more accessible to end consumers, while new opportunities across B2B channels and pharmacies will be activated throughout the region.

Health and Innovation – A Shared Vision

"We warmly welcome Vitabiotics Turkey to the Prisum Healthcare family!" said Ionela Nicolau, CEO of Prisum Healthcare.

"Today we take another step forward in executing our growth strategy. We reaffirm our commitment to providing people with access to high-quality, science-backed products. Turkey represents a vital gateway to regional scale, and Vitabiotics’ respected brand portfolio and strong local team will contribute significantly to driving sustainable growth."

Vitabiotics and Prisum Healthcare share a long-term vision of becoming trusted global partners in healthcare, leveraging their expertise in dietary supplements and human blood plasma-derived medicines, while fostering innovation, excellence, and value centred on consumers and patients.

Media coverage of the acquisition in Romanian outlets:

	Business Magazin
	Ziarul Financiar

* * *

About Prisum Healthcare

Prisum Healthcare is a leading healthcare company dedicated to improving patient well-being through high-quality nutritional products and life-saving human blood plasma-derived therapies. With decades of experience and a portfolio that includes trusted international brands in dietary supplements, plasma-derived therapies, and wellness solutions, Prisum Healthcare operates across multiple European markets and continues its global expansion.

The company is committed to consumers and patients by delivering products designed to improve health and overall quality of life.

About Vitabiotics

Vitabiotics Ltd. is a leading UK-based nutraceutical company, founded in 1971, renowned for its science-backed vitamins, minerals, and dietary supplements for all ages, including well-known brands such as Pregnacare, Wellman, Wellwoman, Perfectil, Menopace, Osteocare, and others. The company has received multiple Queen’s Awards for Innovation and International Trade and is committed to evidence-based research and nutritional support.